O. Kucukhuseyin Et Al. , "The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease," IN VIVO , vol.29, no.3, pp.371-378, 2015
Kucukhuseyin, O. Et Al. 2015. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease. IN VIVO , vol.29, no.3 , 371-378.
Kucukhuseyin, O., Toptas, B., Timirci-Kahraman, O., Isbir, S., Karsidag, K., & Isbir, T., (2015). The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease. IN VIVO , vol.29, no.3, 371-378.
Kucukhuseyin, Özlem Et Al. "The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease," IN VIVO , vol.29, no.3, 371-378, 2015
Kucukhuseyin, Özlem Et Al. "The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease." IN VIVO , vol.29, no.3, pp.371-378, 2015
Kucukhuseyin, O. Et Al. (2015) . "The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease." IN VIVO , vol.29, no.3, pp.371-378.
@article{article, author={Özlem KÜÇÜKHÜSEYİN Et Al. }, title={The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease}, journal={IN VIVO}, year=2015, pages={371-378} }